Personal tools

Coexpression cluster:C2409: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=DOID:14566!3.93e-11!239;DOID:162!1.27e-10!235
|ontology_enrichment_disease=DOID:14566!3.93e-11!239;DOID:162!1.27e-10!235
|ontology_enrichment_uberon=UBERON:0001637!1.27e-15!42;UBERON:0003509!1.27e-15!42;UBERON:0004572!1.27e-15!42;UBERON:0002049!1.74e-15!79;UBERON:0007798!1.74e-15!79;UBERON:0000486!4.98e-15!82;UBERON:0000490!8.44e-15!138;UBERON:0003914!1.02e-14!118;UBERON:0004290!1.56e-14!70;UBERON:0001981!2.48e-14!60;UBERON:0007500!2.48e-14!60;UBERON:0004537!2.48e-14!60;UBERON:0006965!2.48e-14!60;UBERON:0000055!5.82e-14!69;UBERON:0000914!1.37e-13!83;UBERON:0002329!1.37e-13!83;UBERON:0003077!1.37e-13!83;UBERON:0003059!1.37e-13!83;UBERON:0007282!1.37e-13!83;UBERON:0009618!1.37e-13!83;UBERON:0007285!1.37e-13!83;UBERON:0005256!6.94e-13!143;UBERON:0004872!9.32e-13!84;UBERON:0003104!1.53e-12!238;UBERON:0009142!1.53e-12!238;UBERON:0001134!3.66e-12!61;UBERON:0002036!3.66e-12!61;UBERON:0003082!3.66e-12!61;UBERON:0002100!6.22e-12!216;UBERON:0004573!1.88e-11!33;UBERON:0004571!1.88e-11!33;UBERON:0002385!1.21e-10!63;UBERON:0001015!1.21e-10!63;UBERON:0000383!1.21e-10!63;UBERON:0004535!9.64e-10!110;UBERON:0001009!1.46e-08!113;UBERON:0001986!2.72e-07!18;UBERON:0004638!2.72e-07!18;UBERON:0004852!2.72e-07!18;UBERON:0000487!5.82e-07!22
|ontology_enrichment_uberon=UBERON:0001637!1.27e-15!42;UBERON:0003509!1.27e-15!42;UBERON:0004572!1.27e-15!42;UBERON:0002049!1.74e-15!79;UBERON:0007798!1.74e-15!79;UBERON:0000486!4.98e-15!82;UBERON:0000490!8.44e-15!138;UBERON:0003914!1.02e-14!118;UBERON:0004290!1.56e-14!70;UBERON:0001981!2.48e-14!60;UBERON:0007500!2.48e-14!60;UBERON:0004537!2.48e-14!60;UBERON:0006965!2.48e-14!60;UBERON:0000055!5.82e-14!69;UBERON:0000914!1.37e-13!83;UBERON:0002329!1.37e-13!83;UBERON:0003077!1.37e-13!83;UBERON:0003059!1.37e-13!83;UBERON:0007282!1.37e-13!83;UBERON:0009618!1.37e-13!83;UBERON:0007285!1.37e-13!83;UBERON:0005256!6.94e-13!143;UBERON:0004872!9.32e-13!84;UBERON:0003104!1.53e-12!238;UBERON:0009142!1.53e-12!238;UBERON:0001134!3.66e-12!61;UBERON:0002036!3.66e-12!61;UBERON:0003082!3.66e-12!61;UBERON:0002100!6.22e-12!216;UBERON:0004573!1.88e-11!33;UBERON:0004571!1.88e-11!33;UBERON:0002385!1.21e-10!63;UBERON:0001015!1.21e-10!63;UBERON:0000383!1.21e-10!63;UBERON:0004535!9.64e-10!110;UBERON:0001009!1.46e-08!113;UBERON:0001986!2.72e-07!18;UBERON:0004638!2.72e-07!18;UBERON:0004852!2.72e-07!18;UBERON:0000487!5.82e-07!22
|pathway_enrichment=1.29278039819306e-07;4.22792693532735e-05;3;92;Ribosome (KEGG):03010!1.33583789425825e-07;4.22792693532735e-05;3;93;Cytoplasmic Ribosomal Proteins (Wikipathways):WP477!4.38101132167368e-06;0.000462196694436573;3;296;Metabolism of proteins (Reactome):REACT_17015!2.47401672121621e-07;5.22017528176621e-05;3;114;Regulation of beta-cell development (Reactome):REACT_13698!1.26014008745975e-05;0.000997085844202525;3;421;Gene Expression (Reactome):REACT_71!5.131046541619e-06;0.000463993208692118;3;312;Diabetes pathways (Reactome):REACT_15380!4.90583318576651e-07;6.21078481318041e-05;3;143;Influenza Infection (Reactome):REACT_6167!4.4062091595204e-07;6.21078481318041e-05;3;138;{RPS27A,138} (Static Module):NA
}}
}}

Revision as of 14:58, 13 July 2012


Full id: C2409_embryonic_Mallassezderived_acute_Endothelial_Smooth_mucinous_iPS



Phase1 CAGE Peaks

Hg19::chr17:41150479..41150500,+p2@RPL27
Hg19::chr18:47018784..47018858,-p1@RPL17
Hg19::chr3:23958661..23958672,+p3@RPL15
Hg19::chr5:180670839..180670850,-p2@GNB2L1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


p.valueFDRnGenesnPathwayName
1.29278039819306e-074.22792693532735e-05392Ribosome (KEGG):03010
1.33583789425825e-074.22792693532735e-05393Cytoplasmic Ribosomal Proteins (Wikipathways):WP477
4.38101132167368e-060.0004621966944365733296Metabolism of proteins (Reactome):REACT_17015
2.47401672121621e-075.22017528176621e-053114Regulation of beta-cell development (Reactome):REACT_13698
1.26014008745975e-050.0009970858442025253421Gene Expression (Reactome):REACT_71
5.131046541619e-060.0004639932086921183312Diabetes pathways (Reactome):REACT_15380
4.90583318576651e-076.21078481318041e-053143Influenza Infection (Reactome):REACT_6167
4.4062091595204e-076.21078481318041e-053138{RPS27A,138} (Static Module):NA



Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0003735structural constituent of ribosome0.00100743510006639
GO:0005840ribosome0.00100743510006639
GO:0030529ribonucleoprotein complex0.00143724057864277
GO:0006412translation0.00143724057864277
GO:0009059macromolecule biosynthetic process0.00248269631372499
GO:0044249cellular biosynthetic process0.00390412900224879
GO:0009058biosynthetic process0.00671554975359331
GO:0005737cytoplasm0.00783500691595296
GO:0043232intracellular non-membrane-bound organelle0.00783500691595296
GO:0043228non-membrane-bound organelle0.00783500691595296
GO:0043025cell soma0.0123445740741651
GO:0003723RNA binding0.0131171125191485
GO:0032991macromolecular complex0.0138540533694944
GO:0044444cytoplasmic part0.0209145093649791
GO:0015934large ribosomal subunit0.0270742205951243
GO:0010467gene expression0.029605707070642
GO:0044267cellular protein metabolic process0.029605707070642
GO:0044260cellular macromolecule metabolic process0.029605707070642
GO:0019538protein metabolic process0.0310029748407682
GO:0044424intracellular part0.0349162005738084
GO:0033279ribosomal subunit0.0410395691737379



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
artery1.27e-1542
arterial blood vessel1.27e-1542
arterial system1.27e-1542
vasculature1.74e-1579
vascular system1.74e-1579
multilaminar epithelium4.98e-1582
unilaminar epithelium8.44e-15138
epithelial tube1.02e-14118
dermomyotome1.56e-1470
blood vessel2.48e-1460
epithelial tube open at both ends2.48e-1460
blood vasculature2.48e-1460
vascular cord2.48e-1460
vessel5.82e-1469
somite1.37e-1383
paraxial mesoderm1.37e-1383
presomitic mesoderm1.37e-1383
presumptive segmental plate1.37e-1383
trunk paraxial mesoderm1.37e-1383
presumptive paraxial mesoderm1.37e-1383
trunk mesenchyme6.94e-13143
splanchnic layer of lateral plate mesoderm9.32e-1384
mesenchyme1.53e-12238
entire embryonic mesenchyme1.53e-12238
skeletal muscle tissue3.66e-1261
striated muscle tissue3.66e-1261
myotome3.66e-1261
trunk6.22e-12216
systemic artery1.88e-1133
systemic arterial system1.88e-1133
muscle tissue1.21e-1063
musculature1.21e-1063
musculature of body1.21e-1063
cardiovascular system9.64e-10110
circulatory system1.46e-08113
endothelium2.72e-0718
blood vessel endothelium2.72e-0718
cardiovascular system endothelium2.72e-0718
simple squamous epithelium5.82e-0722
Disease
Ontology termp-valuen
disease of cellular proliferation3.93e-11239
cancer1.27e-10235


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.